Focal HIFU versus prostate surgery: cost and quality of life
Part of Cancer, Kidney & urinary clinical trials.
This trial compares focal HIFU (a targeted heating treatment inside the prostate) with prostate surgery, looking at overall cost and quality of life. It may help people with certain early, limited prostate cancers understand which option fits best for them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 45–75, with early prostate cancer that has not been treated yet (or is on active surveillance).
- Your biopsy and MRI match a “favorable intermediate risk” pattern: mostly Gleason 3+3 (ISUP 1) with limited Gleason 3+4 (ISUP 2) in one side of the prostate.
- Your MRI shows the tumor, and biopsy has confirmed it (done by the center’s normal biopsy method).
- Your PSA blood test is under 20, and your prostate size is under 150 ml.
- You must be able and willing to sign consent and do required follow-up testing at about 1 year, including a biopsy after HIFU.
- You should not have medical or anatomy reasons that prevent MRI with contrast or prevent the endorectal HIFU probe from being safely placed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares how two treatments—total prostate removal or focal HIFU (a targeted ultrasound therapy)—affect quality of life in men with favorable intermediate-risk prostate cancer who are sexually active. It aims to help patients choose the best option for their lifestyle.
This trial studies a focused ultrasound treatment called HIFU for prostate cancer that appears limited to the early stages. It aims to treat cancer within the prostate while avoiding treatment spread to lymph nodes or distant organs.
This trial compares two ways to treat early prostate cancer: a single small surgery through the bladder versus high-intensity focused ultrasound (HIFU). It aims to see which approach works better while keeping side effects and recovery acceptable.
This study collects data on men with early, low-risk prostate cancer who choose to have a targeted ultrasound treatment called HIFU (High-Intensity Focused Ultrasound). It looks at how well this treatment works and how men recover.
This trial studies whether a high-intensity focused ultrasound treatment can help people with localized prostate cancer while still avoiding traditional full-dose treatment for some patients. It may be an option for certain intermediate-risk cases where the cancer is confined to the prostate.
This observational study looks at outcomes after people choose HIFU (high-intensity focused ultrasound) to treat only a targeted area of the prostate. It may help doctors better understand how well HIFU works and what follow-up imaging or testing shows over time.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.